Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1709465.7Aexternal-prioritypatent/GB201709465D0/en
Priority claimed from GBGB1709526.6Aexternal-prioritypatent/GB201709526D0/en
Priority claimed from GBGB1805990.7Aexternal-prioritypatent/GB201805990D0/en
Priority claimed from GBGB1805989.9Aexternal-prioritypatent/GB201805989D0/en
Priority claimed from GBGB1805991.5Aexternal-prioritypatent/GB201805991D0/en
Priority claimed from GBGB1806779.3Aexternal-prioritypatent/GB201806779D0/en
Priority claimed from GBGB1806780.1Aexternal-prioritypatent/GB201806780D0/en
Application filed by 4D Pharma Res LtdfiledCritical4D Pharma Res Ltd
Publication of MA50273ApublicationCriticalpatent/MA50273A/en
Publication of MA50273B1publicationCriticalpatent/MA50273B1/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
L'invention concerne des compositions comprenant des souches bactériennes pour le traitement et la prévention d'une affection neurodégénérative.The invention relates to compositions comprising bacterial strains for the treatment and prevention of neurodegenerative disease.